Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

Jerry H. Gurwitz, Terry S. Field, Leslie R. Harrold et al. · JAMA · 2003 · 1.7K citations

Pharmacy, Gynecology, Obstetrics +11

A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

Carl J. Pepine, Eileen Handberg, Rhonda M. Cooper‐DeHoff et al. · JAMA · 2003 · 1.3K citations

Medicine, Cardiology, Pharmacology +17

Prognostic Value of a Treadmill Exercise Score in Outpatients with Suspected Coronary Artery Disease

Daniel B. Mark, Linda K. Shaw, Frank E. Harrell et al. · New England Journal of Medicine · 1991 · 835 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15

Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

Charles Antzelevitch, Luiz Belardinelli, Andrew C. Zygmunt et al. · Circulation · 2004 · 678 citations · Full text

Medicine, Cardiology, Pharmacology +17

Effects of Ranolazine With Atenolol, Amlodipine, or Diltiazem on Exercise Tolerance and Angina Frequency in Patients With Severe Chronic Angina<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Bernard Chaitman · JAMA · 2004 · 676 citations

Pharmacy, Pharmacology, Pharmacotherapy +17